chr10:80828723-81076285 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
chr10:80828723-81076285 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
chr10:80828723-81076285 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
chr10:80828723-81076285 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
chr10:80828723-81076285 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
chr10:80828723-81076285 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
chr10:80828723-81076285 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
chr10:80828723-81076285 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
chr10:80828723-81076285 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
chr10:80828723-81076285 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
chr10:80828723-81076285 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
chr10:80828723-81076285 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
chr10:80828723-81076285 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
chr10:80828723-81076285 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
chr10:80828723-81076285 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
chr10:80828723-81076285 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
chr10:80828723-81076285 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
chr10:80828723-81076285 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
chr10:80828723-81076285 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
chr10:80828723-81076285 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
chr10:80828723-81076285 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
chr10:80828723-81076285 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
chr10:80828723-81076285 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
chr10:80828723-81076285 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
chr10:80828723-81076285 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
chr10:80828723-81076285 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
chr10:80828723-81076285 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
chr10:80828723-81076285 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
chr10:80828723-81076285 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
chr10:80828723-81076285 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
chr10:80828723-81076285 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
chr10:80828723-81076285 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
chr10:80828723-81076285 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
chr10:80828723-81076285 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
chr10:80828723-81076285 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
chr10:80828723-81076285 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
chr10:80828723-81076285 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
chr10:80828723-81076285 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
chr10:80828723-81076285 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
chr10:80828723-81076285 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
chr10:80828723-81076285 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
chr10:80828723-81076285 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
chr10:80828723-81076285 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
chr10:80828723-81076285 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
chr10:80828723-81076285 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
chr10:80828723-81076285 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
chr10:80828723-81076285 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
chr10:80828723-81076285 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
chr10:80828723-81076285 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
chr10:80828723-81076285 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
chr10:80828723-81076285 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
chr10:80828723-81076285 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
chr10:80828723-81076285 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
chr10:80828723-81076285 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
chr10:80828723-81076285 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
chr10:80828723-81076285 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
chr10:80828723-81076285 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
chr10:80828723-81076285 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
chr10:80828723-81076285 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
chr10:80828723-81076285 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
chr10:80828723-81076285 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
chr10:80828723-81076285 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
chr10:80828723-81076285 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Inflammatory bowel disease (early onset) |
intron |
6e-09 |
GWASdb |
chr10:80828723-81076285 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Crohn's disease |
intron |
1e-30 |
GWASdb |
chr10:80828723-81076285 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
chr10:80828723-81076285 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
chr10:80828723-81076285 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
chr10:80828723-81076285 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |